期刊文献+

配合物[M(C_(14)H_(10)N_4)_2·HPO_4]·0.25H_2O(M=Cd,Mn)的水热合成、晶体结构及荧光性质 被引量:3

Hydrothermal Syntheses, Crystal Structures and Photoluminescence Property of Complexes [M(C_(14)H_(10)N_4)_2·HPO_4]·0.25H_2O(M=Cd,Mn)
下载PDF
导出
摘要 通过水热反应,合成了2种新的2,2′-联苯并咪唑超分子配合物[M(C14H10N4)2·HPO4]·0.25H2O(配合物1:M=Cd,配合物2:M=Mn)。经元素分析、红外光谱、热重对其结构进行了表征,用X-射线单晶衍射测定了该化合物的晶体结构。两晶体均为三斜晶系,P1空间群,均由1个M髤离子、2个2,2′-联苯并咪唑分子、1个磷酸氢根阴离子及0.25个结晶水组成。其中2,2′-联苯并咪唑分子中的碱性氮原子和磷酸氢根阴离子中的氧原子与M髤离子配位,形成6配位的畸变八面体构型。分子之间通过氢键N-H…O和π-π堆积作用相互构成二维层状超分子结构。室温固态荧光测试显示,配合物1在491.0nm(λmax)具有强的荧光发射。 Two new supermolecular complexes, [M(2,2′-dibenzimidazole)2·HPO4]·0.25H2O (complex 1: M=Cd, complex 2: M=Mn) were synthesized by the hydrothermal reaction of o-diaminobenzene, oxalic acid with CdSO4 or MnSO4 in 10% H3PO4 solution, and were characterized by elemental analysis, IR spectral analysis and thermogravimetric analysis. Their crystal structures were determined by the X-ray single crystal diffraction, which show that both of them belong to triclinic system and space group P1 with similar crystal parameters. Each of them consists of a M(Ⅱ) ion, two 2,2′-dibenzimidazole units, a hydrogen phosphate ion and 0.25 crystal water molecule in the single cell. The coordinated geometry of the centre metal atom with four nitrogen atoms and two oxygen atoms is the distorted octahedral configuration. Two 2D layer supermolecular complex systems are formed by the hydrogen bonds N -H … O and π-π stacking interactions between neighboring single cells. Complex 1 shows a strong fluorescent emission (λmax=491.0 nm) at solid state.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2010年第9期1663-1668,共6页 Chinese Journal of Inorganic Chemistry
基金 河南省科技厅重点科技攻关项目(No092102310309)资助
关键词 2 2′-联苯并咪唑 镉髤配合物 锰髤配合物 晶体结构 光致发光 2 2′-dibenzimidazole cadmium(Ⅱ) complex manganese(Ⅱ) complex crystal structure photoluminescence
  • 相关文献

参考文献14

  • 1Evans T M,Gardiner J M.Mahmood N,et al.Bioorg.Med.Chem.Lett.,1997,7(4):409-412.
  • 2LIYan(李焱) MAHui-Qing(马会强) WANGYu-Lu(王玉炉).Youji Huaxue,2008,28(2):210-217.
  • 3Craigo W A,Lesueur B W,Skibo E B.J.Med.Chem.,1999,42(17):3324-3333.
  • 4LI Wei(李薇) LI Chang-Hong(李昶红) YANG Ying-Qu (杨颖群) et al.Wuji Huaxue Xuebao,2008,24(8):1360-1364.
  • 5LI Wei(李薇) LI Chang-Hong(李昶红) YANG Ying-Qun(杨颖群) et al.wuji Huaxue Xuebao,2009,25(2):369-372.
  • 6FENG Lj(冯莉) TIAN Jin-Lei(田金磊) YAN Shi-Ping(阎世平) et al.Nankai Daxue Xuebao,2008,41(1):51-56.
  • 7GUOYing-Chen(郭应臣) SUNRu-Zhong(孙汝中) QIAOZan-Ping(乔占平) etal.Wuji Huaxue Xuebao,2009,25(8):1447-1451.
  • 8TANGZhi-Wei(唐治炜) FUJun-Dan(傅君丹) FENGXia(封霞) etal.Wuji Huaxue Xuebao,2009,25(8):1402-1407.
  • 9GUO Ying-Chen(郭应臣) ZHUO Li-Hong(卓立宏) QIAO Zan-Ping(乔占平) et al.Wuji Huaxue Xuebao,2008,24(1):15-20.
  • 10Sheldrick G M.SHELXL,Program for the Solution and the Refinement of Crystal Structures,Universitat Gt(o)tingen,Germany,1997.

二级参考文献31

共引文献2

同被引文献17

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部